SCHEDULE: Glazer Capital and Paul J. Glazer Disclose 7.3% Passive Stake in IGM Biosciences

Glazer Capital, LLC and its managing member, Paul J. Glazer, have disclosed a passive beneficial ownership of 7.3% in IGM Biosciences, Inc.'s common stock.

Summary

• Glazer Capital, LLC and Paul J. Glazer collectively reported beneficial ownership of 2,534,803 shares of IGM Biosciences, Inc. Common Stock.
• This ownership represents 7.30% of the outstanding class of securities.
• The reporting persons, Glazer Capital, LLC (a Delaware limited liability company and investment manager) and Paul J. Glazer (a U.S. citizen and Managing Member of Glazer Capital), share both voting and dispositive power over all reported shares.
• The shares were acquired for investment purposes and not with the intent to change or influence control of IGM Biosciences, Inc., consistent with a passive investment strategy.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a significant passive investment stake by an investment firm in a publicly traded company, common in the financial industry for transparency regarding large shareholdings.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by Glazer Capital and Paul J. Glazer provides transparency regarding the ownership structure of IGM Biosciences, Inc., which can influence market perception and trading activity.

Key Dates

Keywords

IGM Biosciences, Glazer Capital, Paul J. Glazer, Beneficial Ownership, Schedule 13G, Common Stock, Investment Manager, Passive Investment